Ajax-Loading

Daiichi Sankyo Co. Ltd. - Ebit

Daiichi Sankyo Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Ebit" stands at 315.66 Billion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2025, the highest value at least since 12/31/2011, the period currently displayed.

Daiichi Sankyo Co. Ltd.'s first quarter result of 96.71 Billion JPY for the item "Ebit" represents an increase of 52.04 percent compared to it's fourth quarter result of the company's last fiscal year.

Also, Daiichi Sankyo Co. Ltd.'s first quarter result of 96.71 Billion JPY for the item "Ebit" represents an increase of 4.01 percent compared to it's first quarter result of last year.

Looking again at the trailing twelve months series (TTM), Daiichi Sankyo Co. Ltd.'s first quarter result of 315.66 Billion JPY for the item "Ebit" represents an increase of 1.20 percent compared to it's fourth quarter result of the company's last fiscal year.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 21.21 percent compared to the value the year prior.
The 1 year change in percent is 21.21.
The 3 year change in percent is 412.11.
The 5 year change in percent is 172.28.
The 10 year change in percent is 202.43.

The Serie's long term average value is 116.46 Billion Japanese Yens. It's latest available value, on 06/30/2025, is 171.04 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2017, to it's latest available value, on 06/30/2025, is +490.54%.
The Serie's change in percent from it's maximum value, on 06/30/2025, to it's latest available value, on 06/30/2025, is 0.0%.

Ebit for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Ebit905,699,262,464.00
LogoJohnson & Johnson - Ebit486,508,953,600.00
LogoAbbVie Inc - Ebit399,570,305,024.00
LogoRoche Holding AG - Ebit317,433,206,677.55
LogoAstraZeneca PLC - Ebit280,205,508,085.11